Pharmaceuticals

China, US and Japan Drugs for Treatment of Breast Cancer Industry 2016 Deep Market Research Report

  • QYR605986
  • 135 Pages
  • June 2016
  • Pharmaceuticals
The global Drugs for Treatment of Breast Cancer market was valued at USD 142 Billion in 2015, which sales in China USD 4.68 Billion, in US 37 Billion, in Japan 6.82 Billion. And is projected to reach USD 210 Billion global by 2021, at a CAGR of 8.14% between 2016 and 2021. Ibrance, the drug star of Pfizer will become a major growth point, which sales USD 7.23 billion in US. Ibrance enter the market in 2015. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Breast Cancer in China, US and Japan market, focuses on price, sales, market share and revenue of each type in China, US and Japan.

Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Faslodex
Hercepti
Perjeta
Kadcyla
Afinitor
Avastin
Tamoxifen Citrate Tablets
Exemestane Tablets
Letrozol Tablets
Capecitabine Tablets
Ibrance

Split by manufacturers, this report focuses on the sales, price of each type, average price of Treatment of Breast Cancer, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Roche
Pfizer
Novartis
AstraZeneca
Yangtze River Pharmaceutical Group
FORWARD
NT Pharma
Jiang Su Heng Rui Medicine


Split by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Non-small-Cell Lung Cancer in US, Western Europe, Japan and China, from 2011 to 2020 (forecast), covering
Established markets
Europe
Emerging Markets
China

With 135 pages, 154 charts and eight chapters, to display the market present situation and future, clearly and deeply.



Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Pharmaceutical Excipients Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Over the Counter (OTC) & Diet Supplementary Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>